Several cross-sectional studies suggest that inflammation may be involved in the development of hypertension. The objective of the study was to examined inflammatory biomarkers -C-reactive protein (CRP), plasma fibrinogen and their correlates among hypertensive population in two tertiary hospitals in Sokoto, Nigeria. A total of 316 hypertensive patients aged 25 to 76 years and 158 age-and sex-matched apparently healthy normotensive subjects seen in the Medical and Out Patient Departments of Usmanu Danfodiyo University Teaching Hospital and Specialist Hospital, Sokoto, Nigeria were included in the study between July and December, 2016. Blood pressure and anthropometric measurements were done using standard techniques. Serum CRP and plasma fibrinogen concentrations were estimated by ELISA and assay kit respectively. The results showed that, CRP, fibrinogen, body mass index (BMI), systolic blood pressure (SBP) and diastolic blood pressure (DBP) were significantly (p˂0.001) higher in hypertensive subjects than normotensive subjects. Significant positive correlations were established between BMI and each of CRP and fibrinogen in hypertensive patients. In conclusion, the results in the current study demonstrates that serum CRP and plasma fibrinogen levels are elevated in hypertensive subjects and positively correlated with BMI. Thus routine measurement of serum CRP and plasma fibrinogen can be a potential tool for early identification of individuals at the risk for development of hypertension and cardiovascular diseases.
INTRODUCTION
Hypertension is one of the most important public health problem in developing countries and one of the major risk factors for cardiovascular diseases. The global burden of hypertension is enormous (Kearney et al., 2004) , and has been recognized as the most common cardiovascular disorder and a leading cause of morbidity and mortality in both developed and developing countries (Goyal and Sarwate, 2014) . Elevated plasma level of low density lipoprotein (LDL) fraction that contributes to hyperlipidaemia has been implicated in the development of atherosclerosis and progression of cardiovascular diseases (Onyeali et al., 2010) .
Hypertension is also characterized by alterations in the structure and function of the cell membrane, and is often associated with metabolic abnormalities including dyslipidaemia (Ikewuchi et al., 2011) .
The reported global prevalence of hypertension varies with the lowest prevalence in rural India (3.4% in men and 6.8% in women) and highest in Poland (68.9% in men and 72.5% in women; (Kearney et al., 2004) . In sub-Sahara Africa, the prevalence is reported as 32.6% (Addo et al., 2007) . The prevalence in Nigeria varied from 11% to 45% (Osuji et al., 2012) . In Sokoto, the reported prevalence of hypertension is 24.8% (Isezuo, 2015) .
A growing body of evidences has shown that vascular inflammation may play a critical role in the initiation and development of hypertension (Li et al., 2005) . Hypertension is thought to be an inflammatory disorder (Bautista et al., 2001; Li et al., 2005) and systemic inflammation may play an important role in the pathogenesis of endothelial dysfunction, leading to functional and structural changes in the endothelium which are more apparent in the early stages of hypertension (Sesso et al., 2015) . A state of inflammation also play a key role in the pathogenesis of a number of chronic inflammatory systemic diseases, which include atherosclerosis, psoriasis, systemic lupus erythematosus and rheumatoid arthritis (Reshma et al., 2011) .
Some cross-sectional studies reported higher plasma C-reactive protein (CRP) concentrations with increases in blood pressure (BP) in treated or untreated patients with hypertension than in normotensive individuals (Pockley et al., 2002; Bautista et al., 2004) . The association between elevated CRP levels and high BP may have three different pathophysiological explanations. Several studies suggest that CRP may induce a decrease in endothelium dependent relaxation, a potential risk factor for hypertension. High BP may however induce inflammation and raise CRP levels (Bautista et al., 2005) . On the other hand, the association could be confounding, because CRP and high BP share several risk factors such as lower socio-demographic position, lack of physical activity, smoking and truncal obesity (Bautista et al., 2005) . Higher CRP concentrations among hypertension might be explained by a clustering of common positive CRP covariates (age, female sex and increased body mass index and lipid concentrations) among hypertensive patients (JNC, 2003) . The clinical relevance of CRP determination in subjects without clinically overt ischemic heart disease is still controversial. A report of the Reykjavik study showed that CRP is an independent predictor of coronary heart disease, though the CRP-associated odds ratio was lower than that of established cardiovascular risk factors such as systolic blood pressure (SBP), smoking and elevation of total cholesterol (TC) (Danesh et al., 2004) .
Plasma fibrinogen is an important component of the coagulation cascade, as well as a major determinant of blood viscosity and blood flow. Increasing evidence from epidemiological studies suggests that elevated plasma fibrinogen levels are associated with an increased risk of cardiovascular disorders, including ischaemic heart disease, stroke and other thromboembolism (Kamath and Lip, 2003) . It may promote a prothrombotic or hypercoagulable states, and may in part explain the risk of stroke and thromboembolism in conditions such as atrial fibrillation (Hajat et al., 2001) . The use of inflammatory markers in predicting the risk of cardiovascular disease is increasingly gaining attention. However, the relationship between CRP and fibrinogen in hypertension has not been studied in Sokoto, Nigeria. The current study examined markers of inflammation-CRP and fibrinogen for their association with blood pressure and body mass index in hypertensive population of African descent in Sokoto.
MATERIALS AND METHODS

Study area
Blood 
Study subjects and blood sample collection
A total of 474 subjects were recruited for the study. These consisted of 316 diagnosed adult male and female hypertensive patients and 158 age-and sex-matched apparently healthy normotensive subjects (controls). Blood samples were collected from hypertensive patients attending Medical and outpatient Clinics, aged 25 to ≥ 76 years, while the controls were recruited from a population of people living in Sokoto metropolis.
Each subject's consent was sought and obtained after the purpose of the study was explained to each of them. Eligibility criteria for the hypertensive patients included those who aged 25 to 76 years with BP values of 140/90 mmHg and above confirmed on two different occasions and provided written informed consent. Study subjects were ineligible if they have any of the following: a) metabolic disorders such as diabetes mellitus, among others, as well as organ diseases such as liver, kidney and gastrointestinal tract (GIT) diseases, b) be pregnant, c) smoke cigarette, abuse alcoholic, d) those who decline to give consent for inclusion.
During blood sample collection, 3ml of venous blood sample was collected from each selected subject using a sterile disposable syringe and needle. Two (2) ml of blood was transferred to plain tubes and allowed to clot at room temperature after which it was centrifuged at 3000 rpm for 5 minutes to obtain a clear unhaemolyzed serum. The sera were harvested and placed in another plain tube and rapidly stored at -20 0 C until the time for analysis. One millilitre of blood was transferred into a bottle containing 111 µl trisodium citrate and centrifuged immediately at 300 x g for 10 minutes and the plasma transferred to plastic container and immediately frozen at -20 0 C until assayed.
Study design
This is a cross sectional study. All the hypertensive patients were evaluated by the Consultant Physicians. At enrolment a structured-interviewer administered questionnaire was used to document the subject's demographic and socioeconomic data including age, sex, marital status, occupation, education and presence of any disease among others.
Blood pressure (BP) and anthropometric measurements
Blood pressure of each subject was measured on a single visit by the Consultant Physician, using a standard mercury sphygmomanometer and appropriate cuff sizes, with the subject in a seated position, and having rested for at least 10 minutes. Three separate readings were taken per subject, after two minutes intervals and the average of the second and third readings recorded. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were taken at the 1 st and 5 th Korotkoff sounds respectively (Ijeh et al., 2010) . Anthropometric parameters of the subjects were measured using standard techniques. Subjects were weighted without shoes, and with minimum clothing to the nearest 0.1 kg by using a regularly calibrated weighing health scale; model ZT 120 (Seca Gmbh and Co., Germany), while for height measurement, the subjects stood erect and barefooted on a regularly calibrated Stadiometer with a movable head piece; model 220 (Seca Gmbh and Co., Germany). The head piece was levelled with the skull vault and height of the subjects read and recorded to the nearest 0.5 cm. BMI for each subject was calculated using the following equation: BMI (kg/m 2 ) = Body Weight (kg)/Height (m 2 ) (Sergio et al., 2007) .
Serum C -reactive protein and plasma fibrinogen measurements Serum concentrations of CRP were estimated by the method described by Chard (1990) using ELISA kit obtained from Labkit Barcelona, Spain. Plasma fibrinogen concentrations were estimated by the assay method described by Schmaier (2012) using kit obtained from Labkit Barcelona, Spain.
Statistical analysis
The data generated were analyzed using statistical package for social sciences (SPSS) version 20. Continuous variables are expressed as mean plus/minus standard error of the mean (Mean  SEM). The results of both the clinical and biochemical parameters obtained from hypertensive patients were compared with those of controls using paired two-tailed student's t-test for matched samples. Correlation of age, BMI and BP with CRP and fibrinogen were carried out using Pearson's linear correlation analysis. A pvalue of less than or equal to 0.05 (p≤ 0.05) was considered as significant.
RESULTS
The demographic and socioeconomic characteristics of hypertensive patients and controls are presented in Table 1 . The result indicated a total of 316 hypertensive patients (155 males and 161 females) and 158 apparently healthy subjects (74 males and 84 females) were recruited respectively. Most of the subjects were within the age range of 41-56 years (43.3%). Most (92.8%) of the subjects were married and were predominantly Hausas (85.9%) by tribes with 39.5% having no formal education. Table 2 shows the anthropometric values of hypertensive patients and controls. The result indicated significantly (p˂0.001) increased body weight, BMI and waist circumference (WC) in hypertensive patients as compared with controls. The mean height in hypertensive patients were not significantly different (p= 0.117) from those of controls. The mean SBP, DBP, CRP and fibrinogen were also significantly (p˂0.001) higher, among hypertensive patients than controls (Table 3) .
The correlation coefficient (r) of age against CRP and fibrinogen is presented in Table 4 . The result showed no significant (r= 0.027; p= 0.629 and r= 0.021; 0.713 respectively) correlation between age and each of CRP and fibrinogen in hypertensive patients. A significant (r= 0.157; p= 0.048) positive correlation was established between age and CRP, while an insignificant (r= -0.063; p= 0.434) negative correlation was observed between age and fibrinogen in controls. The correlation between blood pressure and each of CRP and fibrinogen among hypertensive patients and controls is presented in Table 5 . The result indicated no significant correlation between SBP and each of CRP and fibrinogen and between DBP and each of CRP and fibrinogen in both hypertensive patients and controls. Table 6 and Figures 1-2 shows the correlation of between BMI and each of plasma fibrinogen and serum CRP in hypertensive patients and controls. A significant positive correlation was established between BMI and each of plasma fibrinogen and serum CRP in hypertensive patients, while a significant positive correlation was also established between plasma fibrinogen in control subjects. Values are number of subjects and percentage in parenthesis; M = male; F = female. Values are mean ± Standard error of mean; n= number of subjects; SBP=systolic blood pressure; DBP=diastolic blood pressure; CRP= C-reactive protein. Values are correlation coefficient (r); CRP= C-reactive protein; SBP = systolic blood pressure; DBP = diastolic blood pressure; p= p-value. Values are correlation coefficient (r); BMI = body mass index; CRP= C-reactive protein; n=number of subjects p= p-value. 
DISCUSSION
In the current study, the increased levels of CRP in hypertensive patients is consistent with the observations of previous studies (Bautista et al., 2001; Susan et al., 2005; Shafi et al., 2010; Rajesh et al., 2013) . This may be attributed to residual inability of the endothelium to produce nitric oxide and prostacyclin resulting to the loss of the vasodilator, antithrombotic and antiatherogenic properties of the vascular endothelium. High BP may in turn induce inflammation and raised CRP levels. Increased BP is also implicated in the promotion of reactive oxygen species generation as evidenced by a significant association between CRP and mononuclear oxidative stress (Yasunari et al., 2002; Shafi et al., 2010) .
This alteration is important in the pathogenesis of hypertension and coronary heart disease. Wang et al. (2003) in their study showed that CRP up-regulates angiotensin II type I receptors in smooth muscle cells. This could result in vasoconstriction and subsequent elevation of BP. In vitro studies also indicates that hypertension can stimulate the release of inflammatory cytokines secondary to biochemical activation, upregulation of monocyte chemo-attractant protein-1 and generation of oxygen species (Susan et al., 2005) .
In untreated human hypertension, CRP levels have been found to be increased dependent on systolic BP levels (Mathias et al., 2006 ). An increase in CRP levels is independently associated with elevated SBP and pulse pressure (but not DBP), as well as with other classical cardiovascular risk factors (Mathias et al., 2006) . CRP is also a strong risk factor for ischemic stroke, independent of the severity of the underlying atherosclerotic event (Mathias et al., 2006) .
The possible mechanisms of elevated serum CRP levels and its effect on hypertension could be as a result of endothelial dysfunction. Sinisalo et al. (2000) have shown that the levels of CRP are an independent determinant of endotheliumdependent vascular function among patients with coronary heart disease. Brief exposure of human subjects to endotoxin and inflammatory cytokines resulting in a glucocorticoid-inhabitable attenuation in the endothelium-dependent venous relaxation response, that took 7 days to recover (endothelia's 'stunning') has previously been demonstrated (Bautista et al., 2001 ). The endothelial `stunning' could be the consequence of the ability of proinflammatory cytokines to inhibit agonist-stimulated generation of nitric oxide and prostacyclin by constitutive enzymes in the endothelial cell (Bautista et al., 2001) . The residual inability of the endothelium to produce nitric oxide and prostacyclin results in the loss of the vasodilator, antithrombotic and antiatherogenic properties of the vascular endothelium. This alteration is important in the pathogenesis of hypertension and coronary heart disease (Bautista et al., 2001) . Elevated levels of CRP, in hypertension could be related to increased levels of biochemical markers of endothelial dysfunction such as plasma levels of von Willebrand factor and tissue plasminogen activator but not due to the titre of antibodies to Helicobacter pylori, Cytomegalovirus or Chlamydia pneumonia. Therefore, noninfectious environmental and genetic factors could result in chronically elevated levels of CRP and hypertension (Bautista et al., 2001) .
The increased level of plasma fibrinogen among hypertensive patients as observed in the current study is consistent with the previous reports (Coban et al., 2004; Anoop et al., 2006) . This could be secondary to increase in shear stress, endothelial dysfunction and progressive vascular disease in hypertension. Several plausible mechanisms could explain an observed association between elevated fibrinogen levels and hypertension, including the relation of fibrinogen to increased viscosity and peripheral vascular resistance, hyperinsulinaemia and insulin resistance (Anoop et al., 2006) . Plasma fibrinogen is also influenced by many factors. The level increases with age, BMI, smoking, and diabetes mellitus (DM) and post menopause, and is related to fasting serum insulin, low density lipoprotein cholesterol (LDL-C), lipoprotein (a) and leukocyte count. Conversely, it decreases with moderate alcohol intake, physical activity, increased high density lipoprotein cholesterol (HDL-C), and with hormone replacement therapy (Sesso et al., 2003) .
The current study demonstrates that, plasma fibrinogen is positively correlated with BMI in hypertensive subjects; this finding indicates that plasma fibrinogen increases with increased BMI (Anoop et al., 2006) , while it is not significantly correlated with age and blood pressure. Similarly CRP positively correlated with BMI and was not significantly correlated with age and BP in hypertensive patients.
Conclusion
The results of the present study confirm that serum CRP and plasma fibrinogen levels are elevated in hypertension and positively correlated with BMI among hypertensive patients. Prospective cohort studies aimed at evaluating the potential benefits of CRP and fibrinogen in the diagnosis, prediction and management of hypertensive patients is hereby suggested.
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